Macquarie Group’s PDL BioPharma, Inc. PDLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-4,227
| Closed | -$13K | – | 2416 |
|
|
2020
Q3 | $13K | Hold |
4,227
| – | – | ﹤0.01% | 2252 |
|
|
2020
Q2 | $12K | Buy |
+4,227
| New | +$12K | ﹤0.01% | 2268 |
|
|
2019
Q1 | – | Sell |
-2,800
| Closed | -$8K | – | 2329 |
|
|
2018
Q4 | $8K | Sell |
2,800
-4,000
| -59% | -$11.4K | ﹤0.01% | 1980 |
|
|
2018
Q3 | $18K | Sell |
6,800
-61,440
| -90% | -$163K | ﹤0.01% | 1924 |
|
|
2018
Q2 | $160K | Sell |
68,240
-231,600
| -77% | -$543K | ﹤0.01% | 1727 |
|
|
2018
Q1 | $882K | Buy |
299,840
+6,800
| +2% | +$20K | ﹤0.01% | 1215 |
|
|
2017
Q4 | $803K | Buy |
293,040
+41,900
| +17% | +$115K | ﹤0.01% | 1302 |
|
|
2017
Q3 | $851K | Buy |
+251,140
| New | +$851K | ﹤0.01% | 1268 |
|
|
2013
Q4 | – | Sell |
-131,764
| Closed | -$1.05M | – | 1675 |
|
|
2013
Q3 | $1.05M | Buy |
131,764
+5,312
| +4% | +$42.3K | ﹤0.01% | 1153 |
|
|
2013
Q2 | $976K | Buy |
+126,452
| New | +$976K | ﹤0.01% | 1157 |
|